Neutralizing antibody titres to SARS-CoV-2 Omicron variant and wild-type virus in those with past infection or vaccinated or boosted with mRNA BNT162b2 or inactivated CoronaVac vaccines.

Peiris, Malik; Cheng, Samuel; Mok, Chris Ka Pun; Leung, Yonna; Ng, Susanna; Chan, Karl; Ko, Fanny; Yiu, Karen; Lam, Bosco; Lau, Eric; Chan, Ken; Luk, Leo; Li, John; Tsang, Leo; Poon, Leo; Chen, Chunke; Hui, David

Peiris, Malik; Cheng, Samuel; Mok, Chris Ka Pun; Leung, Yonna; Ng, Susanna; Chan, Karl; Ko, Fanny; Yiu, Karen; Lam, Bosco; Lau, Eric; Chan, Ken; Luk, Leo; Li, John; Tsang, Leo; Poon, Leo; Chen, Chunke; Hui, David.

Afiliación

Peiris M; University of Hong Kong.
Cheng S; University of Hong Kong.
Mok CKP; Chinese University of Hong Kong.
Leung Y; University of Hong Kong.
Ng S; Chinese University of Hong Kong.
Chan K; University of Hong Kong.
Ko F; Chinese University of Hong Kong.
Yiu K; Chinese University of Hong Kong.
Lam B; North Lantau Hospital.
Lau E; University of Hong Kong.
Chan K; Chinese University of Hong Kong.
Luk L; University of Hong Kong.
Li J; University of Hong Kong.
Tsang L; University of Hong Kong.
Poon L; University of Hong Kong.
Chen C; Chinese University of Hong Kong.
Hui D; The Chinese University of Hong Kong.

Res Sq ; 2022 Jan 05.

Article en En | MEDLINE | ID: mdl-35018372

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Res Sq Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Res Sq Año: 2022 Tipo del documento: Article